https://www.selleckchem.com/products/fg-4592.html
Randomized controlled trials (RCTs) are considered the gold standard for evidence-based medicine, and although a well-designed and executed RCT can be extremely powerful, many RCTs have significant flaws that may significantly impact the strength of their conclusions. The fragility index is a metric that objectifies the strength of results from RCTs and is one such metric that should be considered when critically evaluating individual studies. Although the RCTs pertaining to hip arthroscopy have a median value of 4, which is slightly gr